FBRX - Forte Biosciences, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
20.41 -1.5 (-7.35%) -0.23 (-1.18%) -0.23 (-1.18%) -0.34 (-1.77%) --- -1.5 (-7.35%) --- ---

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.96
Diluted EPS:
-0.96
Basic P/E:
-19.6979
Diluted P/E:
-19.6979
RSI(14) 1m:
48.79
VWAP:
19.06
RVol:

Events

Period Kind Movement Occurred At

Related News